Incorporation of glucose into lipid-linked saccharides in aorta and its inhibition by amphomycin.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects / Q000378:metabolism*; D006017:Glycolipids / Q000096:biosynthesis*; D006023:Glycoproteins / Q000096:biosynthesis; D006155:Guanosine Diphosphate Mannose / Q000378:metabolism; D007700:Kinetics; D055666:Lipopeptides; D009842:Oligopeptides / Q000494:pharmacology; D013552:Swine; D014532:Uridine Diphosphate Glucose / Q000378:metabolism*; D014539:Uridine Diphosphate Sugars / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D006017:Glycolipids; D006023:Glycoproteins; D055666:Lipopeptides; D009842:Oligopeptides; D014539:Uridine Diphosphate Sugars; D006155:Guanosine Diphosphate Mannose; C004423:amphomycin; D014532:Uridine Diphosphate Glucose